Molecular Modeling-(B)ased Delivery System Enhances Everolimus-Induced Apoptosis in Caco-2 Cells

[Image: see text] Several studies have shown that the mammalian target of rapamycin (mTOR) inhibitor; everolimus (EV) improves patient survival in several types of cancer. However, the meaningful efficacy of EV as a single agent for the treatment of colorectal cancer (CRC) has failed to be proven in...

Descripción completa

Detalles Bibliográficos
Autores principales: Maki, Marwan Abdelmahmoud Abdelkarim, Kumar, Palanirajan Vijayaraj, Cheah, Shiau-Chuen, Siew Wei, Yeong, Al-Nema, Mayasah, Bayazeid, Omer, Majeed, Abu Bakar Bin Abdul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649008/
https://www.ncbi.nlm.nih.gov/pubmed/31459966
http://dx.doi.org/10.1021/acsomega.9b00109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649008/
https://www.ncbi.nlm.nih.gov/pubmed/31459966
http://dx.doi.org/10.1021/acsomega.9b00109

Ejemplares similares